• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸酯酶2通过调节VEGF-D促进乳腺癌淋巴管生成。

Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D.

作者信息

Zhu Chenfang, Qi Xiaoliang, Zhou Xin, Nie Xin, Gu Yan

机构信息

Department of General Surgery, Shanghai Ninth People's Hospital, Affiliated with Shanghai Jiaotong University, School of Medicine, Shanghai 200011, P.R. China.

Department of Surgery, George Washington University, Washington, DC 20052, USA.

出版信息

Oncol Rep. 2016 Dec;36(6):3161-3171. doi: 10.3892/or.2016.5143. Epub 2016 Oct 4.

DOI:10.3892/or.2016.5143
PMID:27748846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5112611/
Abstract

In our previous studies, sulfatase 2 (Sulf2) was found to upregulate vascular endothelial growth factor-D (VEGF-D) expression in breast cancer. As VEGF-D plays an important role in lymphangiogenesis, we hypothesized that Sulf2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D. To evaluate the functions of Sulf2 on lymphangiogenesis in breast cancer, proliferation, apoptosis, cell cycle, cell mobility and tube-formation of lymphatic endothelial cells (LECs) were measured in vitro. Lymphangiogenesis in nude mouse ears and breast cancer xenografts were examined in vivo. Furthermore, the expression levels of related signaling pathway genes were screened and verified in LECs. We found that Sulf2 significantly increased the mobility and tube formation of the LECs, inhibited cisplatin-induced LEC apoptosis, but had no effect on cell proliferation and the cell cycle. Moreover, recombinant Sulf2 (rSulf2) combined with VEGF-D further promoted the proliferation, cell cycle, mobility and tube-like structure formation in the LECs, and at the same time inhibited cisplatin-induced apoptosis especially in the late stage. Sulf2 also significantly increased the density of lymphatic vessels in mouse ears and breast cancer xenografts in vivo. AKT1 was also shown to be upregulated and activated by Sulf2. Our results confirmed that Sulf2 facilitated lymphangiogenesis in breast cancer cells by regulating VEGF-D and that the AKT1‑related signaling pathway was involved.

摘要

在我们之前的研究中,发现硫酸酯酶2(Sulf2)可上调乳腺癌中血管内皮生长因子-D(VEGF-D)的表达。由于VEGF-D在淋巴管生成中起重要作用,我们推测Sulf2通过调节VEGF-D促进乳腺癌中的淋巴管生成。为了评估Sulf2在乳腺癌淋巴管生成中的功能,在体外测量了淋巴管内皮细胞(LEC)的增殖、凋亡、细胞周期、细胞迁移和管形成。在体内检查了裸鼠耳部和乳腺癌异种移植物中的淋巴管生成。此外,在LEC中筛选并验证了相关信号通路基因的表达水平。我们发现Sulf2显著增加了LEC的迁移和管形成,抑制了顺铂诱导的LEC凋亡,但对细胞增殖和细胞周期没有影响。此外,重组Sulf2(rSulf2)与VEGF-D联合进一步促进了LEC的增殖、细胞周期、迁移和管状结构形成,同时尤其在后期抑制了顺铂诱导的凋亡。Sulf2还显著增加了体内小鼠耳部和乳腺癌异种移植物中淋巴管的密度。AKT1也显示被Sulf2上调并激活。我们的结果证实,Sulf2通过调节VEGF-D促进乳腺癌细胞中的淋巴管生成,并且涉及AKT1相关信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/b6b92a7385c1/or-36-06-3161-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/c3ec49ded6f2/or-36-06-3161-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/86d53f1650ac/or-36-06-3161-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/971f474daf36/or-36-06-3161-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/19b8180d60cf/or-36-06-3161-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/17830e1db6bd/or-36-06-3161-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/1388437ce829/or-36-06-3161-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/579c8cad059d/or-36-06-3161-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/b6b92a7385c1/or-36-06-3161-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/c3ec49ded6f2/or-36-06-3161-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/86d53f1650ac/or-36-06-3161-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/971f474daf36/or-36-06-3161-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/19b8180d60cf/or-36-06-3161-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/17830e1db6bd/or-36-06-3161-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/1388437ce829/or-36-06-3161-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/579c8cad059d/or-36-06-3161-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b4/5112611/b6b92a7385c1/or-36-06-3161-g07.jpg

相似文献

1
Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D.硫酸酯酶2通过调节VEGF-D促进乳腺癌淋巴管生成。
Oncol Rep. 2016 Dec;36(6):3161-3171. doi: 10.3892/or.2016.5143. Epub 2016 Oct 4.
2
Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.结肠癌转移相关蛋白1上调血管内皮生长因子C/D以促进人胃癌淋巴管生成。
Cancer Lett. 2015 Feb 1;357(1):242-253. doi: 10.1016/j.canlet.2014.11.035. Epub 2014 Nov 18.
3
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.硫酸酯酶2通过调节一些肿瘤相关因子促进乳腺癌进展。
Oncol Rep. 2016 Mar;35(3):1318-28. doi: 10.3892/or.2015.4525. Epub 2015 Dec 28.
4
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.一种潜在的小分子合成抗淋巴管生成剂去甲斑蝥素通过在体外和体内阻断VEGF-A、-C、-D/VEGFR-2、-3“多点启动”机制来抑制人结肠腺癌的肿瘤生长和淋巴管生成。
BMC Cancer. 2015 Jul 19;15:527. doi: 10.1186/s12885-015-1521-5.
5
CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.CPT1A 通过 VEGF 信号通路调节乳腺癌相关淋巴管生成。
Biomed Pharmacother. 2018 Oct;106:1-7. doi: 10.1016/j.biopha.2018.05.112. Epub 2018 Jun 23.
6
Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.肿瘤坏死因子超家族成员15(Tnfsf15)通过上调淋巴管内皮细胞中Vegfr3基因的表达促进淋巴管生成。
J Pathol. 2015 Nov;237(3):307-18. doi: 10.1002/path.4577. Epub 2015 Aug 6.
7
Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.采用去甲斑蝥素同时阻断 VEGF-C 和 VEGF-D/VEGFR-3 抑制人淋巴管内皮细胞淋巴管生成。
Int J Oncol. 2012 Nov;41(5):1762-72. doi: 10.3892/ijo.2012.1603. Epub 2012 Aug 23.
8
[Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].白细胞介素7及其受体促进非小细胞肺癌细胞增殖并诱导淋巴管生成
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):511-8. doi: 10.3760/cma.j.issn.0529-5807.2012.08.002.
9
Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.白细胞介素7上调乳腺癌细胞中的血管内皮生长因子D并在体内诱导淋巴管生成。
Br J Surg. 2005 Mar;92(3):305-10. doi: 10.1002/bjs.4832.
10
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.CCL21/CCR7趋化因子轴在乳腺癌诱导的淋巴管生成中的作用。
Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

引用本文的文献

1
6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets.肿瘤转移中的6-O-硫酸酯酶:硫酸乙酰肝素蛋白聚糖修饰及潜在治疗靶点
Am J Cancer Res. 2024 Feb 25;14(2):897-916. doi: 10.62347/RXVE7097. eCollection 2024.
2
SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.SULF2是一种用于伴有淋巴转移的高级别膀胱癌的新型诊断和预后标志物。
Ann Transl Med. 2021 Sep;9(18):1439. doi: 10.21037/atm-21-4102.
3
Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.

本文引用的文献

1
SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.SULF2表达是肺癌潜在的诊断和预后标志物。
PLoS One. 2016 Feb 16;11(2):e0148911. doi: 10.1371/journal.pone.0148911. eCollection 2016.
2
Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma.脂联素(SULF2抑制剂)在肝细胞癌中的化学预防和肝保护作用
Biol Chem. 2016 Mar;397(3):257-67. doi: 10.1515/hsz-2015-0265.
3
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.
从患有淋巴管肌瘤病的肺部组织中分离和鉴定淋巴管内皮细胞。
Sci Rep. 2021 Apr 16;11(1):8406. doi: 10.1038/s41598-021-88064-3.
4
Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer.靶向 TRAF3IP2 比 Rab27 更能有效抑制乳腺癌的发展和转移。
Sci Rep. 2020 Jun 1;10(1):8834. doi: 10.1038/s41598-020-64781-z.
5
Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.人表皮生长因子受体2(HER2)对三叶因子3(TFF3)表达的抑制作用的解除介导了HER2阳性/雌激素受体(ER)阳性乳腺癌中曲妥珠单抗的耐药性。
Oncotarget. 2017 Jun 9;8(43):74188-74208. doi: 10.18632/oncotarget.18431. eCollection 2017 Sep 26.
硫酸酯酶2通过调节一些肿瘤相关因子促进乳腺癌进展。
Oncol Rep. 2016 Mar;35(3):1318-28. doi: 10.3892/or.2015.4525. Epub 2015 Dec 28.
4
Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines.HER2阴性晚期乳腺癌的全身治疗方法——指南解读
Curr Oncol. 2015 Mar;22(Suppl 1):S29-42. doi: 10.3747/co.22.2360.
5
Gene expression profiling of circulating tumor cells in breast cancer.循环肿瘤细胞中乳腺癌的基因表达谱分析。
Clin Chem. 2015 Jan;61(1):278-89. doi: 10.1373/clinchem.2014.229476. Epub 2014 Nov 19.
6
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.肝素酶和硫酸酯酶在肿瘤微环境中修饰硫酸乙酰肝素蛋白聚糖中的作用及新型癌症治疗的机会。
Front Oncol. 2014 Jul 24;4:195. doi: 10.3389/fonc.2014.00195. eCollection 2014.
7
SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression.SULF1/SULF2 剪接变异体差异调节胰腺肿瘤生长进展。
Exp Cell Res. 2014 Jun 10;324(2):157-71. doi: 10.1016/j.yexcr.2014.04.001. Epub 2014 Apr 12.
8
The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.SULFs(硫酸乙酰肝素的细胞外硫酸酯酶)可促进角膜上皮细胞在创伤修复过程中的迁移。
PLoS One. 2013 Aug 8;8(8):e69642. doi: 10.1371/journal.pone.0069642. eCollection 2013.
9
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.VEGF-D 的前肽决定肝素结合、受体异二聚化以及对肿瘤生物学的影响。
J Biol Chem. 2013 Mar 22;288(12):8176-8186. doi: 10.1074/jbc.M112.439299. Epub 2013 Feb 12.
10
Role of heparan sulfatases in ovarian and breast cancer.硫酸乙酰肝素酶在卵巢癌和乳腺癌中的作用。
Am J Cancer Res. 2013;3(1):34-45. Epub 2013 Jan 18.